As shown earlier, LD-RT decreases pain in patients with chronic degenerative and inflammatory diseases, which is, at least for Rheumatoid arthritis (RA), thought to be related to reduced activation of OC (41). Here, BGLAP is linked to rheumatoid arthritis.